Immix Biopharma Inc (IMMX)
Healthcare
Biotechnology
8.30 $
-2.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Immix Biopharma Inc (IMMX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -9.8 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.5 | -3.1 | -2.7 | -3.8 | -5.3 | -4.0 | -1.5 | -1.7 | -5.3 | -5.9 | -11 | -9.8 | -32 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | |
| 0.4 | 0.7 | 1.1 | 0.9 | 0.6 | 0.7 | 0.7 | 0.9 | 0.5 | 0.5 | 0.6 | 0.6 | 2.1 | |
| 0.4 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.4 | 0.5 | 1.4 | 0.5 | -1.5 | 2.4 | 2.6 | 1.9 | 0.7 | 1.1 | -1.0 | -0.5 | 0.3 | |
| 0.0 | 0.0 | 0.0 | 0.3 | 0.1 | 0.3 | 0.5 | 0.1 | 0.1 | 0.4 | 0.2 | 0.0 | 0.7 | |
| – | 0.0 | 0.0 | -0.3 | -0.1 | -0.3 | -0.5 | -0.1 | -0.1 | -0.4 | -6.6 | -4.8 | -12 | |
| – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | |
| 4.7 | 10 | 0.6 | 16 | 16 | 0.0 | 0.0 | 0.0 | 1.1 | 11 | 96 | 0.0 | 107 | |
| 1.2 | 6.9 | -2.1 | 12 | -5.3 | -4.3 | -2.0 | -1.8 | -4.3 | 4.3 | 78 | -15 | 63 | |
| -3.5 | -3.1 | -2.7 | -4.1 | -5.4 | -4.3 | -2.0 | -1.8 | -5.4 | -6.3 | -11 | -9.9 | -33 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.